Subchronic treatment with amino acid mixture of L-lysine and L-arginine modifies neuroendocrine activation during psychological stress in subjects with high trait anxiety

Nutritional Neuroscience

Volumn 8, Issue 3, 2005, Pages 155-160

  Jezova, Daniela ^a   Makatsori, Aikaterini ^a   Smriga, Miro ^b   Morinaga, Yasushi ^b   Duncko, Roman ^a  

^a INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^b AJINOMOTO CO INC   (Japan)

Author keywords

Anxiety; Hormones; L arginine; L lysine; Mental stress; Skin conductance

Indexed keywords

ADRENALIN; AMINO ACID; ARGININE; CORTICOTROPIN; HYDROCORTISONE; LYSINE; NORADRENALIN;

ADULT; ANXIETY; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTRODERMAL RESPONSE; HEART RATE; HORMONE RESPONSE; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL STRESS; NEUROENDOCRINE SYSTEM; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN CONDUCTANCE; SPEECH; TASK PERFORMANCE; TRANQUILIZING ACTIVITY;

ADRENOCORTICOTROPIC HORMONE; ADULT; ANXIETY; ARGININE; BLOOD PRESSURE; DOUBLE-BLIND METHOD; EPINEPHRINE; GALVANIC SKIN RESPONSE; HEART RATE; HUMANS; HYDROCORTISONE; LYSINE; MALE; NEUROSECRETORY SYSTEMS; NOREPINEPHRINE; PLACEBOS; SALIVA; SPEECH; STRESS, PSYCHOLOGICAL;

EID: 23644460203     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1080/10284150500162937     Document Type: Article

References (36)

1. Barbul A, Lazarou SA, Efron DT, Wasserkrug HL, Efron G. 1990. Arginine enhances wound healing and lymphocyte immune responses in humans. Surgery 108:331-336.
2. Chang YF, Gao XM. 1995. L-lysine is a barbiturate-like anti-convulsant and modulator of the benzodiazepine receptor. Neurochem Res 20:931-937.
3. Chang YF, Wang Y, Cauley RK, Gao XM. 1993. Chronic L-lysine develops anti-pentylenetetrazol tolerance and reduces synaptic GABAergic sensitivity. Eur J Pharmacol 233:209-217.
4. Dunn RW, Reed TA, Copeland PD, Frye CA. 1998. The nitric oxide synthase inhibitor 7-nitroindazole displays enhanced anxiolytic efficacy without tolerance in rats following subchronic administration. Neuropharmacology 37:899-904.
5. Evoy D, Lieberman MD, Fahey TJ, III, Daly JM. 1998. Immunonutrition: The role of arginine. Nutrition 14:611-617.
6. Fernstrom JD. 2000. Can nutrient supplements modify brain function? Am J Clin Nutr 71:1669S-1675S.
7. Flodin NW. 1997. The metabolic roles, pharmacology, and toxicology of lysine. J Am Coll Nutr 16:7-21.
8. Gonzalez-Bono E, Moya-Albiol L, Salvador A, Carrillo E, Ricarte J, Gomez-Amor J. 2002. Anticipatory autonomic response to a public speaking task in women: The role of trait anxiety. Biol Psychol 60:37-49.
9. Kathol RG, Gehris TL, Carroll BT, Samuelson SD, Pitts AF, Meller WH, Carter JL. 1992. Blunted ACTH response to hypoglycemic stress in depressed patients but not in patients with schizophrenia. J Psychiatr Res 26:103-116.
10. Harkin A, Connor TJ, Walsh M, St John N, Kelly JP. 2003. Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors. Neuropharmacology 44:616-623.
11. Jezova D, Duncko R. 2002. Enhancement of stress-induced pituitary hormone release and cardiovascular activation by antidepressant treatment in healthy men. J Psychopharmacol 16:235-240.
12. Jezova D, Duncko R, Lassanova M, Kriska M, Moncek F. 2002. Reduction of rise in blood pressure and cortisol release during stress by Ginkgo biloba extract (EGb 761) in healthy volunteers. J Physiol Pharmacol 53:337-348.
13. Jezova D, Vigas M. 1988. Apomorphine injection stimulates beta-endorphin, adrenocorticotropin, and cortisol release in healthy man. Psychoneuroendocrinology 13:479-485.
14. Jezova D, Makatsori A, Duncko R, Moncek F, Jakubek M. 2004. High trait anxiety in healthy subjects: Association with low neuroendocrine responses during psychosocial stress. Prog Neuro-psychopharmacol Biol Psychiatry 28:1331-1336.
15. Kario K, McEwen BS, Pickering TG. 2003. Disasters and the heart: A review of the effects of earthquake-induced stress on cardiovascular disease. Hypertens Res 26:355-367.
16. Kirschbaum C, Pirke K, Hellhammer DH. 1993. The 'Trier Social Stress Test' - a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28:76-81.
17. Makatsori A, Duncko R, Moncek F, Loder I, Katina S, Jezova D. 2004. Modulation of neuroendocrine response and non-verbal behavior during psychosocial stress in healthy volunteers by the glutamate release inhibiting drug lamotrigine. Neuroendocrinology 79:34-42.
18. Masood A, Banerjee B, Vijayan VK, Ray A. 2003. Modulation of stress-induced neurobehavioral changes by nitric oxide in rats. Eur J Pharmacol 458:135-139.
19. Mills PJ, Dimsdale JE. 1991. Cardiovascular reactivity to psychosocial stressors. A review of the effects of beta-blockade. Psychosomatics 32:209-220.
20. Nieves C, Jr, Langkamp-Henken B. 2002. Arginine and immunity: A unique perspective. Biomed Pharmacother 56:471-482.
21. Obled C, Papet I, Breuille D. 2002. Metabolic bases of amino acid requirements in acute diseases. Curr Opin Clin Nutr Metab Care 5:189-197.
22. Ohta Y, Nishida K. 2002. L-arginine protects against stress-induced gastric mucosal lesions by preserving gastric mucus. Clin Exp Pharmacol Physiol 29:32-38.
23. Peuler JD, Johnson GA. 1977. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci 21:625-636.
24. Rozanski A, Blumenthal JA, Kaplan J. 1999. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 99:2192-2217.
25. Shi HP, Most D, Efron DT, Witte MB, Barbul A. 2003. Supplemental L-arginine enhances wound healing in diabetic rats. Wound Repair Regen 11:198-203.
26. Smriga M, Kameishi M, Uneyama H, Torii K. 2002. Dietary L-lysine deficiency increases stress-induced anxiety and fecal excretion in rats. J Nutr 132:3744-3746.
27. Smriga M, Torii K. 2003a. Prolonged treatment with L-lysine and L-arginine reduces stress-induced anxiety in an elevated plus maze. Nutr Neurosci 6:125-128.
28. Smriga M, Torii K. 2003b. L-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats. Proc Natl Acad Sci USA 100:15370-15375.
29. Smriga M, Ghosh S, Mouneimne Y, Pellett PL, Scrimshaw NS. 2004. Lysine fortification reduces anxiety and lessens stress in family members in economically weak communities in northwest Syria. Proc Natl Acad Sci USA 101:8285-8288.
30. Spielberger CD, Gorsuch RL, Lushene RE. 1970. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.
31. Srinongkote S, Smriga M, Nakagawa K, Toride Y. 2003. A diet fortified with L-lysine and L-arginine reduces plasma cortisol and blocks anxiogenic response to transportation in pigs. Nutr Neurosci 6:283-289.
32. Tyrer P. 1992. Anxiolytics not acting at the benzodiazepine receptor: Beta blockers. Prog Neuro-psychopharmacol Biol Psychiatry 16:17-26.
33. Volke V, Wegener G, Bourin M, Vasar E. 2003. Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice. Behav Brain Res 140:141-147.
34. West SG, Likos-Krick A, Brown P, Mariotti F. 2005. Oral L-arginine improves hemodynamic responses to stress and reduces plasma homocysteine in hypercholesterolemic men. J Nutr 135:212-217.
35. Wilken JA, Smith BD, Tola K, Mann M. 2000. Trait anxiety and prior exposure to non-stressful stimuli: Effects on psychophysiological arousal and anxiety. Int J Psychophysiol 37:233-242.
36. Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H. 2000. Hormonal evidence for altered responsiveness to social stress in major depression. Neuropsychopharmacology 23:411-418.